Musclepharm Corporation filed a motion in the US Bankruptcy Court seeking the extension of its exclusivity periods on April 10, 2023. As per the motion, the debtor seeks to extend its exclusivity periods for both, to file a plan by 169 days up to September 30, 2023 and to solicit votes on a plan up to December 15, 2023. The debtor's current exclusivity period to file its plan would expire on April 14, 2023.